US Life Expectancy Reaches New High

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 10 No 12
Volume 10
Issue 12

WASHINGTON-Life expectancy in the United States reached 76.9 years in 2000, a record high, according to preliminary figures released by the Centers for Disease Control and Prevention. CDC attributed the increase in part to continuing declines in the aged-adjusted death rates for cancer and heart disease, the nation’s two leading causes of death.

WASHINGTON—Life expectancy in the United States reached 76.9 years in 2000, a record high, according to preliminary figures released by the Centers for Disease Control and Prevention. CDC attributed the increase in part to continuing declines in the aged-adjusted death rates for cancer and heart disease, the nation’s two leading causes of death.

Mortality from HIV infection decreased 3.7% last year, its fifth consecutive year of decline. Adjusted death rates also fell for other leading causes of death: homicide, suicide, accidents or "unintentional injuries," strokes, diabetes, chronic lower respiratory diseases, and chronic liver disease and cirrhosis.

Mortality increased for Alzheimer’s disease, influenza, pneumonia, kidney disease, hypertension, septicemia, and pneumonitis due to solids and liquids, an age-related illness that made the top 15 causes of death for the first time.

Recent Videos
Talent shortages in the manufacturing and administration of cellular therapies are problems that must be addressed at the level of each country.
Administering oral SERD-based regimens may enhance patients’ quality of life when undergoing treatment for ER-positive, HER2-negative breast cancer.
4 experts in this video
4 experts in this video
Distance and training represent 2 major obstacles to making radiotherapy available to more patients with cancer across the world.
7 experts are featured in this series.
Point-of-care manufacturing, scalable manufacturing, and bringing the cost down [can help].
Louis Potters, MD, FASTRO, FABS, FACR, describes how evidence-based radiation protocols may integrate with novel artificial intelligence software.
Related Content